BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 22261129)

  • 1. Multiple-dose vaginal misoprostol and single-dose misoprostol plus oxytocin for termination of second-trimester pregnancy.
    Zangeneh M; Malek-Khosravi S; Veisi F; Rezavand N; Rezaee M; Rajatee M
    Int J Gynaecol Obstet; 2012 Apr; 117(1):78-80. PubMed ID: 22261129
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second-trimester labor induction.
    Ramsey PS; Savage K; Lincoln T; Owen J
    Obstet Gynecol; 2004 Jul; 104(1):138-45. PubMed ID: 15229013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-dose vaginal misoprostol versus concentrated oxytocin plus low-dose vaginal misoprostol for midtrimester labor induction: a randomized trial.
    Nuthalapaty FS; Ramsey PS; Biggio JR; Owen J
    Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1065-70. PubMed ID: 16157113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second trimester pregnancy termination including fetal death: comparison of five different methods.
    Yapar EG; Senöz S; Urkütür M; Batioglu S; Gökmen O
    Eur J Obstet Gynecol Reprod Biol; 1996 Nov; 69(2):97-102. PubMed ID: 8902440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mifepristone followed by misoprostol or oxytocin for second-trimester abortion: a randomized controlled trial.
    Elami-Suzin M; Freeman MD; Porat N; Rojansky N; Laufer N; Ben-Meir A
    Obstet Gynecol; 2013 Oct; 122(4):815-820. PubMed ID: 24084539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13 to 29 weeks of amenorrhea. A prospective randomized trial].
    Hidar S; Fekih M; Chaïeb A; Bibi M; Mellouli R; Khaïri H
    J Gynecol Obstet Biol Reprod (Paris); 2001 Sep; 30(5):439-43. PubMed ID: 11598557
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaginal misoprostol versus intravenous oxytocin for the management of second-trimester pregnancies with intrauterine fetal death: A randomized clinical trial.
    Abediasl Z; Sheikh M; Pooransari P; Farahani Z; Kalani F
    J Obstet Gynaecol Res; 2016 Mar; 42(3):246-51. PubMed ID: 26663590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of intravenous oxytocin to vaginal misoprostol for mid trimester labor induction.
    Hidar S; Jerbi M; Khaïri H
    Am J Obstet Gynecol; 2006 Jul; 195(1):332-3; author reply 333-4. PubMed ID: 16813766
    [No Abstract]   [Full Text] [Related]  

  • 9. Randomized controlled trial of misoprostol for second-trimester pregnancy termination associated with fetal malformation.
    Akoury HA; Hannah ME; Chitayat D; Thomas M; Winsor E; Ferris LE; Einarson TR; Seaward PG; Ryan G; Willan AR; Windrim R
    Am J Obstet Gynecol; 2004 Mar; 190(3):755-62. PubMed ID: 15042010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of two regimens of intravaginal misoprostol for termination of second trimester pregnancy: a randomized comparative trial.
    Wong KS; Ngai CS; Yeo EL; Tang LC; Ho PC
    Hum Reprod; 2000 Mar; 15(3):709-12. PubMed ID: 10686224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-dose vaginal misoprostol with or without Foley catheter for late second-trimester pregnancy termination in women with previous multiple cesarean sections.
    El Sharkwy IAE; Elsayed ML; Ahmed MA; Alnemer AAA
    J Matern Fetal Neonatal Med; 2019 Nov; 32(22):3703-3707. PubMed ID: 29742942
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of two regimens of misoprostol for second trimester medical termination of pregnancy: a randomized trial.
    Chaudhuri S; Banerjee PK; Mundle M; Mitra SN
    Trop Doct; 2010 Jul; 40(3):144-8. PubMed ID: 20555044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial of 6 and 12 hourly administration of vaginal misoprostol for second trimester pregnancy termination.
    Herabutya Y; Chanrachakul B; Punyavachira P
    BJOG; 2005 Sep; 112(9):1297-301. PubMed ID: 16101611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the abortion interval of second trimester pregnancy termination using misoprostol.
    Ting WH; Peng FH; Lin HH; Lu HF; Hsiao SM
    Taiwan J Obstet Gynecol; 2015 Aug; 54(4):408-11. PubMed ID: 26384060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two regimens of vaginal misoprostol in second trimester termination of pregnancy: a prospective randomised trial.
    Bhattacharyya SK; Mukherji J; Kamilya GS; Ray S; Hazra A
    Acta Obstet Gynecol Scand; 2006; 85(12):1458-62. PubMed ID: 17260222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal misoprostol and intravenous oxytocin for success of termination in the second-trimester intrauterine fetal demise: A randomized controlled clinical trial.
    Asadi N; Vafaei H; Hessami K; Darabi MH; Kasraeian M; Faraji A; Alavi A; Abdi N; Gissuei A; Roozmeh S; Bazrafshan K; Gharibpour F
    J Obstet Gynaecol Res; 2022 Apr; 48(4):966-972. PubMed ID: 35261120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of two regimens of misoprostol for early second-trimester pregnancy termination.
    Guix C; Palacio M; Figueras F; Bennasar M; Zamora L; Coll O; Cararach V
    Fetal Diagn Ther; 2005; 20(6):544-8. PubMed ID: 16260893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaginal misoprostol for second-trimester pregnancy termination after one previous cesarean delivery.
    Naguib AH; Morsi HM; Borg TF; Fayed ST; Hemeda HM
    Int J Gynaecol Obstet; 2010 Jan; 108(1):48-51. PubMed ID: 19781700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of misoprostol for therapeutic termination of pregnancy from 10 -28 weeks of gestation.
    Naz S; Sultana N
    J Pak Med Assoc; 2007 Mar; 57(3):129-32. PubMed ID: 17432017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized study on the effect of adding oxytocin to ethacridine lactate or misoprostol for second-trimester termination of pregnancy.
    Kelekci S; Erdemoglu E; Inan I
    Acta Obstet Gynecol Scand; 2006; 85(7):825-9. PubMed ID: 16817081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.